Get our guide to planning and executing an M&A communications strategy. Download Now

Westicke Partners

Close

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

What to Do After You File Your S-1

Posted on March 12th, 2020. Posted by

S-1 Checklist

During the year (or more) before your company goes public, you’ll be in a constant state of activity, from building relationships with investors, bankers, and sell-side analysts, to engaging in test-the-waters meetings. However, once your S-1 flips public, the U.S. Securities and Exchange Commission (SEC) requires that you wait 15 days before your road show begins. That doesn’t mean you should sit back and relax, though. Use this checklist to maintain your company’s momentum and progress during this time.

Continue Reading

4 Critical Elements of an Effective IR Website

Posted on February 20th, 2020. Posted by

IR website

Any company looking to attract market attention today shouldn’t underestimate the importance of a sophisticated corporate website with a high quality investor relations section.

Potential investors interested in learning more about your firm will likely visit your website before anything else, so put your best foot forward by making your IR website appealing and its pages informative and easy to navigate.

Continue Reading

The Importance of Patient Advocacy in Drug Development

Posted on February 6th, 2020. Posted by

Patient advocacy

Patient advocacy is a part of public relations that has always held a special place in my heart. It’s easy for us in the healthcare industry to get so caught up in our day-to-day to-do lists that we forget the reason (namely who) we are actually working for. Patient advocacy is the piece that brings it back home. I’ve been in the industry long enough to have seen a lot of change in how healthcare companies include patients in what they’re doing, and I’m proud to say that we’ve made huge strides and are continuing to advance toward the place where patients are full partners.

Continue Reading

3 Predictions About the IPO Market in 2020

Posted on January 9th, 2020. Posted by

IPO predictions

Financial markets are notoriously difficult to predict. However, armed with decades of Wall Street experience, our investor relations professionals know what can create a strong IPO market — and what can close that window of opportunity.

As we enter the new year, there are several factors to consider for companies that may be considering an IPO. Based on our experience, here are our predictions for the life sciences IPO market in 2020.
Continue Reading

How to Conduct a Perception Audit

Posted on December 18th, 2019. Posted by

Perception Audit

Finding out how others view your company can be intimidating, but to make sure your business is headed in the right direction, it’s necessary. A perception audit — an independent investigation into investor and analyst impressions of a company — can help you benchmark your progress over time, identify ways to improve your investor relations plan, and pinpoint any misperceptions in market views. Learn the basics of how to conduct a successful perception audit with this checklist.

Continue Reading

Control the Narrative: 4 Ways to Integrate Investor Relations and Public Relations

Posted on December 12th, 2019. Posted by

IR and PR Integration

In today’s world of ubiquitous, instantaneous, and interconnected information, integrated communication should be a key strategic priority for all companies. However, it is even more important in the healthcare space, especially for early stage, pre-revenue life sciences companies, where the investor story is indistinguishable from the product or technology story.

Many companies struggle to unify their message and deliver a cohesive story to the marketplace. As a consequence, the many other voices in the arena — competitors, analysts, key opinion leaders, regulators, investors, advocacy groups, the media, and others — shape the perception of your company for you.

Continue Reading

Keys to Successful Disclosure of Clinical Trial Data and Milestones

Posted on November 21st, 2019. Posted by

Clinical Disclosure

For publicly traded healthcare companies, clinical trial data and milestone disclosure can present great opportunities as well as significant challenges.

On the path toward regulatory approval, life science and medical device company management will encounter difficult disclosure decisions surrounding clinical and regulatory events. Finding the right balance between the “duty to disclose” vs. “pressure to disclose” dilemma is not easy. If done right, such milestones are a great way to raise visibility within the investment, clinical and scientific communities. If done wrong, the consequences may be severe.

Continue Reading

5 Critical Elements of a Successful R&D Day

Posted on November 14th, 2019. Posted by

Hosting an R&D Event

The decision to host a company research and development (R&D) event for investors and analysts should not be taken lightly. Beyond the associated costs, the amount of time it takes to properly prepare is a big endeavor and can be a significant distraction to a company’s management team. Continue Reading

5 Steps to Develop Your Company’s Crisis Communications Plan

Posted on October 31st, 2019. Posted by

Crisis Communications Planning

Any company, no matter how diligent, can find itself suddenly thrust into a crisis — a natural disaster, product safety issue, whistleblower claim, or other unforeseen emergency. When an incident occurs, especially one that disrupts operations or threatens the company’s reputation, stakeholders, be they customers, shareholders or partners, will want to immediately know what happened and how they’re affected. Mishandling the crisis can exacerbate the problem and shake public trust, causing long-lasting harm. And in the current era of instantaneous digital and social media communications, if you don’t communicate during an urgent situation, others may get there first and define it for you.

Continue Reading

Why You Need an IPO Communications Strategy Well Before the IPO

Posted on October 23rd, 2019. Posted by

IPO Communications Strategy

As the rock ‘n’ roll generation begins settling into their senior years, the “Baby Boomer factor” is wielding its heavy influence on healthcare as it has on other industries. Healthcare spending has grown substantially over the past few decades, and demand will likely remain strong as the number of Americans aged 65 and older will more than double by 2060. At the same time, technologies such as artificial intelligence, blockchain, software-as-a-medical-device and other advances are transforming the healthcare industry and threatening the status quo through rich networks of connection, collaboration, and interdependence.

Continue Reading

Planning an investor day?

Investor days — whether virtual on in-person — should play a key role in your investor relations strategy. Use our new eBook, How to Host a Successful Investor Day, to plan and coordinate your next event.

Our Locations